The FDA reviewed a planned interim analysis of Moderna vaccine data, but said assessors did not verify all data from a second submission the sponsor sent later. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
